aspartic acid has been researched along with ALS - Amyotrophic Lateral Sclerosis in 105 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.95) | 18.7374 |
1990's | 30 (28.57) | 18.2507 |
2000's | 37 (35.24) | 29.6817 |
2010's | 33 (31.43) | 24.3611 |
2020's | 4 (3.81) | 2.80 |
Authors | Studies |
---|---|
Batlle, C; Carrera-García, L; Codina, A; Expósito-Escudero, J; Garcia-Cabau, C; Hoenicka, J; Jou, C; Nascimento, A; Natera-de Benito, D; Olival, J; Ortez, C; Palau, F; Roldan, M; Salvatella, X | 1 |
Blicher, JU; Eskildsen, SF; Figlewski, K; Møller, AT; Near, J; Stærmose, TG | 1 |
Barberis, M; Brunetti, M; Calvo, A; Cammarosano, S; Canosa, A; Chiò, A; De Marco, G; Grassano, M; Manera, U; Moglia, C; Vasta, R | 1 |
Abe, T; Haji, S; Harada, M; Izumi, Y; Kaji, R; Matsumoto, Y; Murakami, N; Osaki, Y; Sako, W | 1 |
Briemberg, H; Eurich, DT; Frayne, R; Genge, AL; Graham, SJ; Hanstock, C; Ishaque, A; Kalra, S; Korngut, L; Luk, C; Seres, P; Srivastava, O; Ta, D; Zinman, L | 1 |
Atassi, N; Cernasov, P; Keil, B; Lawson, R; Long, CJ; Murphy, A; Paganoni, S; Ratai, EM; Ratti, E; Rosen, B; Salibi, N; Seethamraju, R; Triantafyllou, C; Xu, M | 1 |
Bagnoli, S; Berti, V; Bessi, V; Braccia, A; Del Mastio, M; Matà, S; Nacmias, B; Piaceri, I; Pignone, AM; Polito, C; Pupi, A; Sorbi, S; Tedde, A | 1 |
Cheong, I; Deelchand, DK; Eberly, LE; Guliani, G; Manousakis, G; Marjańska, M; Öz, G; Walk, D | 1 |
Arahuetes, RM; de Munck, E; Gil, C; Martínez, A; Miguel, BG; Muñoz-Sáez, E; Ojeda, I; Solas, MT | 1 |
D'Angelo, S; Daniele, L; Galletti, P; Monsurrò, MR; Raimo, M; Salvatore, A; Trojsi, F | 1 |
Abdolvahabi, A; Cook, NP; Kohn, T; Marti, AA; Rhodes, NR; Shaw, BF; Shi, Y | 1 |
Brunetti, A; Cervo, A; Cocozza, S; Giorgio, SMDA; Marsili, A; Morra, VB; Palma, V; Quarantelli, M; Saccà, F; Tedeschi, E; Vacca, G | 1 |
Barthelme, D; Jauregui, R; Sauer, RT | 1 |
Abe, T; Harada, M; Izumi, Y; Kaji, R; Sako, W | 1 |
Blanquer, M; García Santos, JM; Gómez Espuch, J; Iniesta, F; Inuggi, A; María Moraleda, J; Martínez, S; Vázquez, C | 1 |
Corsini, S; Nistri, A; Tortora, M | 1 |
Chen, W; Li, X; Lin, H; Luo, J; Sun, G; Wang, Y; Wang, Z; Xu, Y | 1 |
Mali, Y; Zisapels, N | 1 |
Beaulieu, C; Concha, L; Hanstock, C; Hui, B; Johnston, W; Kalra, S; Pyra, T; Wong, JC | 1 |
Ishige, K; Ito, Y; Kosuge, Y; Negi, H; Sekikawa-Nishida, K | 1 |
Fiszman, ML; Latini, A; Ricart, KC; Rodríguez, G; Sica, RE | 1 |
Choi, JK; Dedeoglu, A; Jenkins, BG; Küstermann, E | 1 |
Govind, V; Maudsley, AA; Schuff, N; Sharma, K; Studholme, C; Young, K | 1 |
Bianchi, F; Bongioanni, P; Canapicchi, R; Frijia, F; Hlavata, H; Lombardo, F; Minichilli, F; Montanaro, D; Rossi, B | 1 |
Mali, Y; Zisapel, N | 1 |
Bittšanský, M; Dobrota, D; Grofik, M; Kurča, E; Nosál', V; Poláček, H; Sivák, S; Turčanová-Koprušáková, M | 1 |
Grieb, P; Matyja, E; Nagańska, E; Rafałowska, J; Taraszewska, A | 1 |
Bernabei, C; Bragato, C; Chiari, A; Gellera, C; Georgoulopoulou, E; Mandrioli, J; Sola, P | 1 |
Caraballo-Miralles, V; Lladó, J; Olmos, G; Tolosa, L | 1 |
Hanstock, C; Hui, B; Johnston, W; Kalra, S; Pyra, T; Sudharshan, N | 1 |
Cifra, A; Nani, F; Nistri, A | 1 |
Camicioli, R; Choi, C; Johnston, W; Kalra, S; Lynch, M; Sekhon, R; Seres, P; Usman, U | 1 |
Bisogni, G; Conte, A; Del Grande, A; Lattante, S; Luigetti, M; Madia, F; Marangi, G; Sabatelli, M; Zollino, M | 1 |
Andersen, PM; Benatar, M; Carew, JD; Gronka, S; Hu, X; Nair, G; Wuu, J | 1 |
Capozzo, R; Ceci, E; D'Errico, E; Leo, A; Livrea, P; Logroscino, G; Mastrapasqua, M; Ruggieri, M; Simone, IL; Tortelli, R; Zoccolella, S | 1 |
Bonanno, G; Bonifacino, T; Caponnetto, C; Carminati, E; Giribaldi, F; Giunti, D; Milanese, M; Morando, S; Principato, MC; Uccelli, A; Vergani, L; Voci, A | 1 |
Callaghan, BC; Chenevert, TL; Edden, RA; Feldman, EL; Foerster, BR; Petrou, M | 1 |
Arheart, KL; Govind, V; Maudsley, AA; Saigal, G; Sharma, KR; Sheriff, S | 1 |
Anna Rossi, PI; Bonanno, G; Bonifacino, T; Di Prisco, S; Giribaldi, F; Milanese, M; Pittaluga, A; Puliti, A; Tacchetti, C; Usai, C | 1 |
Jenkinson, M; Knight, S; Maudsley, AA; Stagg, CJ; Talbot, K; Turner, MR | 1 |
Chawla, S; Elman, LB; Grossman, M; Maudsley, AA; McCluskey, LF; Melhem, ER; Poptani, H; Sheriff, S; Verma, G; Wang, S; Woo, JH | 1 |
Arnold, DL; Caramanos, Z; Cashman, NR; Genge, A; Kalra, S | 1 |
Del Corona, A; Filosto, M; Mancuso, M; Murri, L; Naini, A; Rocchi, A; Sartucci, F; Siciliano, G | 1 |
Arnold, DL; Genge, A; Kalra, S | 1 |
Shigeri, Y; Shimamoto, K | 1 |
Askmark, H; Persson, LI; Ryberg, H | 1 |
Fukada, K; Hirata, S; Nagano, S; Nakanishi, T; Okuno, T; Sakoda, S; Sato, T; Shimizu, A; Sugai, F; Yamamoto, Y; Zhou, Z | 1 |
Cai, Y; Gao, Y; Guo, X; Li, D; Liang, Y; Lim, CC; Ma, L; Yin, H | 1 |
Arnold, DL; Kalra, S | 1 |
Gelinas, DF; Miller, RG; Rule, RR; Schuff, N; Suhy, J; Weiner, MW | 1 |
Banci, L; Bertini, I; D'Amelio, N; Gaggelli, E; Libralesso, E; Matecko, I; Turano, P; Valentine, JS | 1 |
Hemptinne, I; Hermans, E; Maloteaux, JM; Tilleux, S; Vanhoutte, N; Vermeiren, C | 1 |
Desiderio, LM; Elman, LB; Krejza, J; McCluskey, LF; Melhem, ER; Poptani, H; Wang, S; Woo, JH | 1 |
Conforti, FL; Gabriele, A; Labella, V; Magariello, A; Majorana, G; Mazzei, R; Monsurrò, MR; Muglia, M; Patitucci, A; Quattrone, A; Simone, IL; Sprovieri, T; Tedeschi, G; Tessitore, A; Ungaro, C; Valentino, P | 1 |
Chao, L; Laxer, K; Meyerhoff, DJ; Mueller, S; Sacrey, DT; Schuff, N; Weiner, MW | 1 |
Arnold, DL; Cashman, NR; Genge, A; Kalra, S; Vitale, A | 1 |
Gordon, P; Lu, J; Mehrazin, M; Mitsumoto, H; Naini, A | 1 |
Chen, L; Huang, H; Liu, Y; Tan, K; Wang, H; Xi, H; Xue, Y; Zhang, F; Zhang, J | 1 |
Kassubek, J; Ludolph, AC; Unrath, A | 1 |
Angenstein, F; Debska-Vielhaber, G; Heinze, HJ; Hilfert, L; Kunz, WS; Leibfritz, D; Ludolph, AC; Niessen, HG; Sander, K; Vielhaber, S; Willker, W | 1 |
Battista, V; Chan, S; Dashnaw, S; Floyd, AG; Gooch, CL; Gordon, PH; Hayes, S; Hays, AP; Hirsch, J; Kaufmann, P; Levin, B; Mao, X; Mitsumoto, H; Montes, J; Pullman, SL; Rowland, LP; Shungu, DC; Tang, MX; Ulug, AM | 1 |
Coutinho, CM; Gatt, JA; Gunawardena, WJ; Jones, AP; Mitchell, JD; Shaw, IC | 1 |
Gredal, O; Møller, SE | 1 |
Chinnery, RM; Ince, PG; Shaw, PJ | 1 |
Fujita, K; Honda, M; Nagata, Y | 1 |
Blin, O; Nieoullon, A; Samuel, D; Serratice, G | 1 |
Dykes-Hoberg, M; Jin, L; Kuncl, RW; Rothstein, JD | 1 |
Constantakakis, E; Plaitakis, A | 1 |
Baudouin, N; Bernard, D; Brunotte, F; Dumas, R; Giroud, M; Lemesle, M; Martin, D; Walker, P | 1 |
Jones, AP; Knight, JM; Redmond, JP; Shaw, IC | 1 |
Gredal, O; Karlsborg, M; Rosenbaum, S; Strange, P; Topp, S; Werdelin, L | 1 |
Appel, SH; Goodman, JC; La Bella, V | 1 |
Andersen, PM; Forsgren, L; Marklund, SL; Nilsson, P | 1 |
Fujii, H; Ichijo, M; Ikeda, K; Irimajiri, S; Iwasaki, Y; Kinoshita, M; Matsuoka, Y | 1 |
Gelinas, D; Maudsley, AA; Miller, RG; Rooney, WD; Schuff, N; Weiner, MW | 1 |
Arnold, DL; Cashman, NR; Genge, A; Kalra, S | 1 |
Eum, WS; Kang, JH; Kim, SM | 1 |
Andrews, C; Dawson, JM; Ellis, CM; Leigh, PN; Simmons, A; Williams, SC | 1 |
Klinkosz, B; Mitsumoto, H; Moore, JK; Ng, TC; Pioro, EP; Trapp, BD; Wang, Y | 1 |
Eum, WS; Kang, JH; Kim, SM; Kwon, OB | 1 |
Majors, AW; Mitsumoto, H; Nelson, DR; Ng, TC; Pioro, EP | 1 |
Janik, P; Niebroj-Dobosz, I | 1 |
Arnold, DL; Cashman, NR; Kalra, S | 1 |
Chan, S; Douglas-Akinwande, A; Lange, DJ; Rowland, LP; Shungu, DC | 1 |
Bowen, BC; Bradley, WG; Pattany, PM; Rotta, F | 1 |
Alexander, GM; Deitch, JS; Del Valle, L; Heiman-Patterson, TD; Seeburger, JL | 1 |
Aĭrapetian, KV; Barkhatova, VP; Nikitin, SS; Zavalishin, IA | 1 |
Kondratyeva, EA; Levitsky, GN; Limborska, SA; Shadrina, MI; Skvortsova, VI; Slominsky, PA; Tupitsina, TV | 1 |
Block, W; Grothe, C; Karitzky, J; Klockgether, T; Lamerichs, R; Pohl, C; Schild, H; Schmidt, S; Träber, F | 1 |
Hahn, D; Kenn, W; Ochs, G; Pabst, TA | 1 |
Abe, K; Fujita, N; Hirabuki, N; Takanashi, M; Tanaka, H; Watanabe, Y; Yanagihara, T | 1 |
Block, W; Grothe, C; Klockgether, T; Pels, H; Pohl, C; Schild, HH; Schmidt, S; Träber, F | 1 |
Elger, CE; Feistner, H; Heinze, HJ; Kanowski, M; Kaufmann, J; Kunz, WS; Sailer, M; Tempelmann, C; Vielhaber, S | 1 |
Bak, MI; Domzał-Stryga, A; Królicki, L; Kwieciński, H | 1 |
Dronsky, V; Gelinas, D; Licht, J; Maudsley, AA; Miller, RG; Rule, R; Schuff, N; Suhy, J; Weiner, MW | 1 |
Cwik, VA; Hanstock, CC; Martin, WR | 1 |
Emeryk-Szajewska, B; Karwańska, A; Kostera-Pruszczyk, A; Niebroj-Dobosz, I; Rowińska-Marcińska, K | 1 |
Janik, P; Kwieciński, H; Niebroj-Dobosz, I | 1 |
Ono, S; Yamauchi, M | 1 |
Blin, O; Guieu, R; Nieoullon, A; Pouget, J; Samuel, D; Serratrice, G | 1 |
Chaudhry, V; Clawson, L; Cornblath, DR; Coyle, JT; Drachman, DB; Kuncl, R; Rothstein, JD | 1 |
Coyle, JT; Hedreen, JC; Kuncl, R; Rothstein, JD; Sim, L; Stauch-Slusher, B; Tsai, GC | 1 |
Martin, DL; Spink, DC | 1 |
Clawson, L; Cornblath, DR; Coyle, JT; Drachman, DB; Kuncl, RW; Pestronk, A; Rothstein, JD; Stauch, BL; Tsai, G | 1 |
Constantakakis, E; Plaitakis, A; Smith, J | 1 |
5 review(s) available for aspartic acid and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
[Excitatory amino acid transporters: development of regulatory molecules for their functional analysis].
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Drug Design; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Receptors, Glutamate | 2003 |
ALS surrogate markers. MRS.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Creatine; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Motor Cortex | 2004 |
N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.
Topics: Aging; Alcoholism; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Brain Injuries; Choline; Cocaine; Creatine; Epilepsy; Ethanol; HIV Infections; Humans; Magnetic Resonance Imaging; Neurodegenerative Diseases; Neurons; Stress Disorders, Post-Traumatic | 2006 |
Biological markers in the diagnosis and treatment of ALS.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Creatine; Disease Progression; Electromyography; Humans; Magnetic Resonance Imaging; Monitoring, Physiologic; Neuroprotective Agents; Riluzole; Tomography, Emission-Computed | 1999 |
[Proton MR spectroscopy studies of the brain in ALS patients].
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Disease Progression; Female; Frontal Lobe; Humans; Magnetic Resonance Spectroscopy; Male; Motor Cortex; Protons; Severity of Illness Index | 2001 |
9 trial(s) available for aspartic acid and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cerebral Cortex; Choline; Creatine; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multimodal Imaging; Pyramidal Tracts; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2015 |
Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Choline; Creatinine; Diffusion Magnetic Resonance Imaging; Disability Evaluation; Disease Progression; Female; Humans; Male; Middle Aged; Phosphocreatine; Pyramidal Tracts; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis: a high-field proton MR spectroscopy study.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Female; Frontotemporal Lobar Degeneration; Gliosis; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Degeneration; Prefrontal Cortex; Protons | 2011 |
A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results.
Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain Chemistry; Brain-Derived Neurotrophic Factor; Feasibility Studies; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Motor Neurons; Placebos; Prospective Studies; Sensitivity and Specificity; Treatment Outcome | 2003 |
A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters.
Topics: Adult; Aged; Amino Acids, Branched-Chain; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cross-Over Studies; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Lamotrigine; Male; Middle Aged; Outcome Assessment, Health Care; Triazines | 2003 |
Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis).
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged | 1995 |
Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Excitatory Amino Acid Antagonists; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motor Cortex; Motor Neurons; Riluzole | 1998 |
Motor unit hyperexcitability in amyotrophic lateral sclerosis vs amino acids acting as neurotransmitters.
Topics: Adult; Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, High Pressure Liquid; Electromyography; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Motor Neurons; Muscle, Skeletal; Neurotransmitter Agents; Reference Values | 2002 |
Effect of Riluzole on serum amino acids in patients with amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Neurotransmitter Agents; Reference Values; Riluzole; Time | 2002 |
91 other study(ies) available for aspartic acid and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Humans; Motor Neurons; Muscular Diseases; Mutation | 2023 |
Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T.
Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Atrophy; Choline; Creatine; Disease Progression; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glutathione; Gray Matter; Hand Strength; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Occipital Lobe; Pilot Projects; Severity of Illness Index; Single-Blind Method | 2019 |
A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation.
Topics: Alanine; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell Cycle Proteins; Female; Genetic Testing; Genetic Variation; Glutamine; Heterozygote; High-Throughput Nucleotide Sequencing; Humans; Male; Membrane Transport Proteins; Middle Aged; Mutation, Missense; Pedigree; Superoxide Dismutase-1; Valine | 2020 |
MR spectroscopy and imaging-derived measurements in the supplementary motor area for biomarkers of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Motor Cortex | 2021 |
Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cognitive Dysfunction; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Prefrontal Cortex; Severity of Illness Index | 2021 |
Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Motor Neurons | 2017 |
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline.
Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; C9orf72 Protein; Cognitive Dysfunction; DNA Mutational Analysis; Female; Fluorodeoxyglucose F18; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Italy; Male; Mental Status and Dementia Tests; Middle Aged; Mutation; Neuropsychological Tests; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Tyrosine | 2018 |
Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Disease Progression; Female; Glutamic Acid; Humans; Longitudinal Studies; Male; Middle Aged; Motor Cortex; Motor Neurons; Pons; Prognosis; Proton Magnetic Resonance Spectroscopy; Upper Extremity | 2019 |
β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Caspase 3; Choline; Creatinine; Cyanobacteria Toxins; Disease Models, Animal; DNA-Binding Proteins; Endoplasmic Reticulum; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Magnetic Resonance Spectroscopy; Male; Mitochondria; Motor Activity; Motor Cortex; Nerve Degeneration; Neurologic Examination; Phenotype; Rats; Rats, Wistar; Spinal Cord; Time Factors | 2013 |
Accumulation of altered aspartyl residues in erythrocyte membrane proteins from patients with sporadic amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Erythrocyte Membrane; Female; Humans; Male; Membrane Proteins; Methionine; Methionine Adenosyltransferase; Middle Aged; Oxidation-Reduction; Oxidative Stress; Protein D-Aspartate-L-Isoaspartate Methyltransferase; Reactive Oxygen Species; S-Adenosylhomocysteine | 2013 |
Deamidation of asparagine to aspartate destabilizes Cu, Zn superoxide dismutase, accelerates fibrillization, and mirrors ALS-linked mutations.
Topics: Amyotrophic Lateral Sclerosis; Asparagine; Aspartic Acid; Humans; Models, Molecular; Molecular Structure; Mutation, Missense; Protein Stability; Superoxide Dismutase; Superoxide Dismutase-1; Temperature | 2013 |
An ALS disease mutation in Cdc48/p97 impairs 20S proteasome binding and proteolytic communication.
Topics: Adenosine Triphosphatases; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell Cycle Proteins; Humans; Hydrolysis; Models, Molecular; Proteasome Endopeptidase Complex; Protein Binding; Protein Transport; Protein Unfolding; Proteolysis; Valosin Containing Protein | 2015 |
The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis.
Topics: Aged; Aging; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Cell Death; Cross-Sectional Studies; Female; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Neurons | 2016 |
Spinal cord infusion of stem cells in amyotrophic lateral sclerosis: Magnetic resonance spectroscopy shows metabolite improvement in the precentral gyrus.
Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell- and Tissue-Based Therapy; Creatine; Female; Frontal Lobe; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Neurons; Pilot Projects; Spinal Cord; Stem Cell Transplantation; Stem Cells | 2016 |
Nicotinic receptor activation contrasts pathophysiological bursting and neurodegeneration evoked by glutamate uptake block on rat hypoglossal motoneurons.
Topics: Action Potentials; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Brain Stem; Endoplasmic Reticulum Stress; Glucosyltransferases; Glutamic Acid; Hypoglossal Nerve; Motor Neurons; Neurodegenerative Diseases; Nicotine; Nicotinic Antagonists; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Nicotinic | 2016 |
Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Creatine; Female; Functional Laterality; Hand; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Statistics, Nonparametric | 2017 |
Gain of interaction of ALS-linked G93A superoxide dismutase with cytosolic malate dehydrogenase.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Cell Line; Cytosol; Humans; Malate Dehydrogenase; Malates; Mice; Mice, Inbred C57BL; Neurons; Superoxide Dismutase | 2008 |
Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Diffusion Tensor Imaging; Disease Progression; Female; Humans; Internal Capsule; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Pyramidal Tracts; ROC Curve; Sensitivity and Specificity | 2010 |
Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Caspase 12; Cell Death; Cell Survival; Disease Models, Animal; Enzyme Activation; Glial Cell Line-Derived Neurotrophic Factor; Glutamic Acid; Mice; Mice, Transgenic; Motor Neurons; Organ Culture Techniques; Spinal Cord; Superoxide Dismutase | 2009 |
In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Cell Survival; Cells, Cultured; Cerebral Cortex; Cerebrospinal Fluid; Female; Glutamic Acid; Humans; Male; Mice; Middle Aged; Neurons; Time Factors | 2010 |
Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Biomarkers; Brain; Creatine; Disease Models, Animal; Glutamic Acid; Glutamine; In Vitro Techniques; Inositol; Linear Models; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Protons; Spectrum Analysis; Superoxide Dismutase | 2009 |
Multivariate statistical mapping of spectroscopic imaging data.
Topics: Adult; Algorithms; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Choline; Creatinine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multivariate Analysis; Reproducibility of Results; Sensitivity and Specificity | 2010 |
VEGF up-regulation by G93A superoxide dismutase and the role of malate-aspartate shuttle inhibition.
Topics: Aminooxyacetic Acid; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Carbon Dioxide; Cell Line, Transformed; Enzyme Inhibitors; Green Fluorescent Proteins; Hybridomas; Hydrogen Peroxide; Hypoxia-Inducible Factor 1, alpha Subunit; Malates; Metabolic Networks and Pathways; Mice; Recombinant Fusion Proteins; Superoxide Dismutase; Up-Regulation; Vascular Endothelial Growth Factor A | 2010 |
Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Creatinine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Neuroprotective effect of erythropoietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural study.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Cell Membrane; Cytoplasm; Endoplasmic Reticulum; Erythropoietin; Nerve Degeneration; Neurons; Neuropil; Neuroprotective Agents; Organ Culture Techniques; Rats; Spinal Cord; Vacuoles | 2010 |
A novel SOD1 mutation in a young amyotrophic lateral sclerosis patient with a very slowly progressive clinical course.
Topics: Adult; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Atrophy; Disease Progression; Electromyography; Humans; Leg; Male; Muscle Weakness; Muscle, Skeletal; Mutation; Peripheral Nerves; Phenotype; Superoxide Dismutase; Superoxide Dismutase-1; Time Factors; Tyrosine | 2010 |
TNF-α potentiates glutamate-induced spinal cord motoneuron death via NF-κB.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Cell Death; Excitatory Amino Acid Transporter 2; Glutamic Acid; Humans; Inflammation; Motor Neurons; NF-kappa B; Organ Culture Techniques; Oxidative Stress; Rats; Signal Transduction; Spinal Cord; Tumor Necrosis Factor-alpha | 2011 |
Degeneration of the mid-cingulate cortex in amyotrophic lateral sclerosis detected in vivo with MR spectroscopy.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Female; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Nerve Degeneration; Neural Pathways; Thalamus | 2011 |
Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block.
Topics: Action Potentials; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Astrocytes; Bicuculline; Biomarkers; Convulsants; Excitatory Amino Acid Antagonists; GABA-A Receptor Antagonists; Glutamic Acid; Hypoglossal Nerve; Motor Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Rats; Riluzole; Strychnine | 2011 |
D11Y SOD1 mutation and benign ALS: a consistent genotype-phenotype correlation.
Topics: Aged; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Genetic Association Studies; Humans; Middle Aged; Mutation; Superoxide Dismutase; Superoxide Dismutase-1; Tyrosine | 2011 |
Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS.
Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Choline; Creatine; Cross-Sectional Studies; Family Health; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mutation; Risk Factors; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Tritium | 2011 |
Serum N-acetylaspartate level in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Chromatography, Liquid; Female; Humans; Italy; Logistic Models; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Middle Aged; Protons | 2011 |
Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Cell Movement; Central Nervous System; Disease Progression; Female; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Transgenic; Motor Activity; Oxidative Stress; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2012 |
Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cross-Sectional Studies; Female; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Protons; Radionuclide Imaging; Young Adult | 2012 |
Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.
Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Choline; Creatine; Humans; Hydrogen; Magnetic Resonance Imaging; Male; Middle Aged; Pyramidal Tracts; Severity of Illness Index | 2012 |
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Autoreceptors; Calcium; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exocytosis; Female; Glutamic Acid; Glycine; Humans; Inositol Phosphates; Lumbar Vertebrae; Male; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Resorcinols; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Synaptosomes | 2013 |
Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS.
Topics: Aged; Amyotrophic Lateral Sclerosis; Anisotropy; Aspartic Acid; Brain; Case-Control Studies; Creatine; Diffusion Magnetic Resonance Imaging; Disability Evaluation; Disabled Persons; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2013 |
Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging.
Topics: Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Brain Mapping; Choline; Creatine; Echo-Planar Imaging; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Retrospective Studies | 2013 |
Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy.
Topics: Acetates; Aged; Amines; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell Survival; Creatine; Cyclohexanecarboxylic Acids; Energy Metabolism; Excitatory Amino Acid Antagonists; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Parietal Lobe; Reference Values; Treatment Outcome | 2003 |
A screening for superoxide dismutase-1 D90A mutation in Italian patients with sporadic amyotrophic lateral sclerosis.
Topics: Adult; Aged; Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; DNA Primers; Female; Genetic Testing; Humans; Italy; Male; Middle Aged; Phenotype; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Superoxide Dismutase; Superoxide Dismutase-1 | 2002 |
Identification of two novel mutations in the Cu/Zn superoxide dismutase gene with familial amyotrophic lateral sclerosis: mass spectrometric and genomic analyses.
Topics: Age of Onset; Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, Liquid; DNA Mutational Analysis; Erythrocytes; Exons; Family Health; Female; Glutamic Acid; Glycine; Histidine; Humans; Male; Molecular Biology; Molecular Sequence Data; Mutation; Precipitin Tests; Spectrometry, Mass, Electrospray Ionization; Superoxide Dismutase | 2004 |
Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis.
Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain Mapping; Case-Control Studies; Creatine; Diffusion Magnetic Resonance Imaging; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Pyramidal Tracts; Spinocerebellar Degenerations | 2004 |
Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Brain Mapping; Choline; Creatine; Cross-Sectional Studies; Female; Functional Laterality; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Reference Values; Tritium | 2004 |
Fully metallated S134N Cu,Zn-superoxide dismutase displays abnormal mobility and intermolecular contacts in solution.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Binding Sites; Circular Dichroism; Copper; Crystallization; Crystallography, X-Ray; Cysteine; Disulfides; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Humans; Hydrogen Bonding; Ions; Magnetic Resonance Spectroscopy; Models, Molecular; Movement; Mutagenesis; Mutation; Polymerase Chain Reaction; Proteins; Spectrophotometry; Superoxide Dismutase; Zinc | 2005 |
Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Aspartic Acid; Astrocytes; Blotting, Northern; Calcium; Carbachol; Cholinergic Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutamic Acid; Humans; Immunohistochemistry; Male; Methoxyhydroxyphenylglycol; Protein Kinase C; Pyridines; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium; Superoxide Dismutase; Tritium | 2006 |
Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T.
Topics: Adult; Age Factors; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Female; Forecasting; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Internal Capsule; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Neuron Disease; Phosphocreatine; Prospective Studies; Pyramidal Tracts | 2006 |
Sporadic ALS is not associated with VAPB gene mutations in Southern Italy.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Base Sequence; Case-Control Studies; Exons; Female; Gene Frequency; Genetic Variation; Glutamic Acid; Humans; Introns; Italy; Male; Middle Aged; Mutation; Vesicular Transport Proteins | 2006 |
Cerebral degeneration predicts survival in amyotrophic lateral sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Case-Control Studies; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Multivariate Analysis; Predictive Value of Tests; Prognosis; Prospective Studies; Survival | 2006 |
Identification of a novel D109Y mutation in Cu/Zn superoxide dismutase (sod1) gene associated with amyotrophic lateral sclerosis.
Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Base Sequence; Catalytic Domain; Central Nervous System; Codon; Disease Progression; DNA Mutational Analysis; Fatal Outcome; Female; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Mutation, Missense; Superoxide Dismutase; Tyrosine | 2007 |
MR spectroscopy evaluation and short-term outcome of olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients.
Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Cell Transplantation; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Olfactory Bulb; Prospective Studies; Protons; Recovery of Function | 2007 |
Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Analysis of Variance; Aspartic Acid; Choline; Creatine; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Statistics, Nonparametric; Time Factors | 2007 |
Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Aspartic Acid; Disease Models, Animal; Disease Progression; gamma-Aminobutyric Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Mutation; Nerve Degeneration; Superoxide Dismutase; Time Factors | 2007 |
Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Creatine; Diffusion Magnetic Resonance Imaging; Female; Follow-Up Studies; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Motor Neuron Disease; Motor Neurons; Muscular Atrophy, Spinal; Neural Conduction; Prospective Studies; Transcranial Magnetic Stimulation | 2007 |
Effect of branched-chain amino acids on glutamate metabolism in amyotrophic lateral sclerosis.
Topics: Adult; Amino Acids, Branched-Chain; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Glutamic Acid; Humans; Male; Middle Aged | 1995 |
[3H]D-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Aspartic Acid; Autoradiography; Female; Humans; Male; Middle Aged; Motor Neuron Disease; Motor Neurons; Muscular Atrophy, Spinal; Receptors, Amino Acid; Spinal Cord | 1994 |
[Free amino acid contents in the spinal cord of amyotrophic lateral sclerosis].
Topics: Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Glutamates; Glutamic Acid; Humans; Male; Middle Aged; Neurotransmitter Agents; Spinal Cord | 1993 |
Changes in CSF amino acid concentrations during the evolution of amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Glutamates; Humans; Male; Middle Aged; Severity of Illness Index | 1994 |
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Biological Transport, Active; Choline O-Acetyltransferase; Disease Models, Animal; Glutamates; Lumbosacral Region; Motor Neurons; Organ Culture Techniques; Pyrrolidonecarboxylic Acid; Rats; Receptors, Glutamate; Spinal Cord; Synaptic Transmission | 1993 |
Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Dipeptides; Humans; Middle Aged; Spinal Cord | 1993 |
Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cell Death; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Middle Aged | 1996 |
Identification of brain metabolites by magnetic resonance spectroscopy in MND/ALS.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Brain Chemistry; Creatine; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy | 1996 |
Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cerebellum; Choline; Creatine; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Muscular Atrophy, Spinal; Protons; Reference Values | 1997 |
Increased CSF glutamate following injection of ALS immunoglobulins.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Glutamic Acid; Immunoglobulins; Injections, Intraperitoneal; Rats; Reference Values; Time Factors | 1997 |
CuZn-superoxide dismutase, extracellular superoxide dismutase, and glutathione peroxidase in blood from individuals homozygous for Asp90Ala CuZu-superoxide dismutase mutation.
Topics: Alanine; Alleles; Amyotrophic Lateral Sclerosis; Aspartic Acid; Erythrocytes; Genetic Carrier Screening; Genotype; Glutathione Peroxidase; Homozygote; Humans; Point Mutation; Superoxide Dismutase | 1998 |
Quantification of brain metabolites in ALS by localized proton magnetic spectroscopy.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Creatine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Motor Cortex; Organ Specificity; Reference Values | 1998 |
Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Pyramidal Tracts; Reference Values; Tissue Distribution | 1998 |
Expression, purification, and characterization of a familial amyotrophic lateral sclerosis-associated D90A Cu,Zn-superoxide dismutase mutant.
Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Chelating Agents; Copper; Free Radicals; Gene Expression; Gene Expression Regulation, Enzymologic; Humans; Recombinant Fusion Proteins; Superoxide Dismutase | 1998 |
A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatinine; Humans; Magnetic Resonance Imaging; Middle Aged; Motor Cortex; Occipital Lobe; Parietal Lobe; Phosphocreatine; Protons | 1998 |
Neuronal pathology in the wobbler mouse brain revealed by in vivo proton magnetic resonance spectroscopy and immunocytochemistry.
Topics: Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; Axons; Caudate Nucleus; Creatine; Disease Models, Animal; Hippocampus; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Mice, Neurologic Mutants; Motor Neuron Disease; Neocortex; Neurofilament Proteins; Neurons; Phosphocreatine; Putamen; Thalamus; Ubiquitins | 1998 |
The free radical-generating function of a familial amyotrophic lateral sclerosis-associated D90A Cu,Zn-superoxide dismutase mutant.
Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Aspartic Acid; Free Radicals; Humans; Kinetics; Mutagenesis, Site-Directed; Point Mutation; Polymerase Chain Reaction; Recombinant Proteins; Superoxide Dismutase; Sweden | 1998 |
1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla.
Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Female; Glutamic Acid; Glutamine; Humans; Hydrogen; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Medulla Oblongata; Middle Aged; Nerve Degeneration; Reference Values | 1999 |
Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS).
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Cell Death; Chromatography, High Pressure Liquid; Excitatory Amino Acids; Female; gamma-Aminobutyric Acid; Glycine; Humans; Male; Middle Aged; Neurons; Neurotransmitter Agents; Severity of Illness Index | 1999 |
Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain.
Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Creatine; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Motor Neuron Disease; Motor Neurons; Pyramidal Tracts; Sensitivity and Specificity | 1999 |
1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain Chemistry; Creatine; Humans; Magnetic Resonance Spectroscopy; Middle Aged | 1999 |
Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acid Transport System X-AG; Amyotrophic Lateral Sclerosis; Animals; Aspartic Acid; ATP-Binding Cassette Transporters; Cerebral Cortex; Extracellular Space; Gene Expression Regulation, Enzymologic; Glutamic Acid; Humans; Hydroxyindoleacetic Acid; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Microdialysis; Phenotype; Superoxide Dismutase | 2000 |
[Physiopathological and chemopathological mechanisms of central motor disorders in amyotrophic lateral sclerosis].
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Electromyography; Female; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Motor Neurons | 2000 |
CuZn-superoxide dismutase gene in sporadic amyotrophic lateral sclerosis patients from Russia: Asp90Ala (D90A) mutation and novel rare polymorphism IVS3+35 A>C.
Topics: Adult; Aged; Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Asian People; Aspartic Acid; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Polymorphism, Genetic; Russia; Superoxide Dismutase; Superoxide Dismutase-1 | 2000 |
Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
Topics: Adult; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Disease Progression; Female; Follow-Up Studies; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Phosphocreatine; Reference Values; Severity of Illness Index | 2001 |
1H spectroscopy in patients with amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Case-Control Studies; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Statistics, Nonparametric | 2001 |
Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Choline; Creatine; Female; Frontal Lobe; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Neurons | 2001 |
Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Electric Stimulation; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Motor Neurons; Neural Conduction; Peripheral Nerves; Predictive Value of Tests; Pyramidal Cells; Transcranial Magnetic Stimulation | 2001 |
Effect of creatine supplementation on metabolite levels in ALS motor cortices.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mitochondria, Muscle; Motor Cortex; Reference Values | 2001 |
Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Choline; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motor Cortex; Reproducibility of Results | 2002 |
Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain Stem; Choline; Creatine; Humans; Magnetic Resonance Spectroscopy; Osmolar Concentration; Reference Values | 2002 |
Glutamate and aspartate are decreased in the skin in amyotrophic lateral sclerosis.
Topics: Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biopsy; Collagen; Female; Glutamates; Glutamic Acid; Humans; Male; Middle Aged; Reference Values; Skin | 1992 |
[Familial amyotrophic lateral sclerosis associated with Huntington chorea with increased aspartate level in the cerebrospinal fluid].
Topics: Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, High Pressure Liquid; Female; Humans; Huntington Disease; Middle Aged | 1992 |
Excitatory amino acids in amyotrophic lateral sclerosis: an update.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, High Pressure Liquid; Glutamates; Glutamic Acid; Humans; Prospective Studies | 1991 |
Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS.
Topics: Amino Acids; Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cerebral Cortex; Dipeptides; Glutamates; Glutamic Acid; Humans; Motor Cortex; Reference Values; Spinal Cord | 1991 |
Excitatory amino acids in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Aspartic Acid; Chromatography, High Pressure Liquid; Glutamates; Humans | 1991 |
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Dipeptides; Female; Glutamates; Humans; Male; Middle Aged; Spinal Cord | 1990 |
The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis.
Topics: Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Aspartic Acid; Brain; Cerebellar Cortex; Cerebral Cortex; Glutamates; Glutamic Acid; Humans; Middle Aged; Neurotoxins; Reference Values; Spinal Cord | 1988 |